Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00775658 · ClinicalTrials.gov registry record · NA
Olopatadine Eye Drops and Allergy Skin Testing
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT00775658 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 24 participants.
The verdict
NCT00775658, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
Use of olopatadine ophthalmic solution (eye drops) will decrease allergy skin test reactivity.
Interventions
- DRUG placebo
- DRUG olopatadine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00775658
The ClinicalTrials.gov registry entry for NCT00775658 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00775658 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00775658 about?
NCT00775658 is a clinical study titled "Olopatadine Eye Drops and Allergy Skin Testing". Use of olopatadine ophthalmic solution (eye drops) will decrease allergy skin test reactivity.
What is the current status of trial NCT00775658?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2008-01. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00775658?
The interventions under investigation include: placebo (DRUG), olopatadine (DRUG).
Who is sponsoring clinical trial NCT00775658?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.